|
People over 80 years of age suffering from a certain type of heart failure do not appear to benefit from most commonly prescribed heart medications, according to a study published in the March 15 issue of the American Journal of Cardiology.
|
Actavis has entered into a consent decree with the FDA to block production at its Totowa, N.J., manufacturing subsidiary until its facilities comply with current good manufacturing practices (cGMP). The decision follows a series of manufacturing problems at the plant, including quality control problems, which allowed oversized tablets of heart failure drug Digitek to be sold publicly, resulting in many deaths and serious injuries.
|
Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).